GSK3335103 is an orally active, non-peptide αvβ6 integrin inhibitor (pIC50=8). GSK3335103 can be used in the study of pulmonary fibrosis[1].
References
[1] Procopiou P A, et al. Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors[J]. Journal of Medicinal Chemistry, 2024. DOI:10.1021/acs.jmedchem.4c01430
